Murat Kalayoglu
Net worth: 123 M $ as of 31/05/2024
Network origin in Murat Kalayoglu first degree
Entity | Entity type | Industry | |
---|---|---|---|
Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cartesian Therapeutics, Inc. manufacturers biological products. The company was founded by Murat Kalayoglu and Michael Singer in 2016 and is headquartered in Gaithersburg, MD.
5
| Subsidiary | Miscellaneous Commercial Services | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Murat Kalayoglu via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ARQULE, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
University of Maryland | College/University | Undergraduate Degree Corporate Officer/Principal | |
University of Wisconsin | College/University | Doctorate Degree Doctorate Degree | |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Biotechnology | Founder | |
View Operating Corp.
View Operating Corp. Industrial SpecialtiesProcess Industries View Operating Corp. engages in the design and manufacture of architectural glass. It offers smart windows and smart building. The company was founded by Paul Nguyen in 2007 and is headquartered in Milpitas, CA. | Industrial Specialties | Director/Board Member | |
Bain & Co., Inc.
Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
NanoDimension Management Ltd.
NanoDimension Management Ltd. Investment ManagersFinance NanoDimension Management (NanoDimension) Ltd is a venture capital firm founded in 2002 by Aymeric Sallin. The firm is headquartered in George Town. | Investment Managers | Chief Executive Officer | |
École Polytechnique Fédérale de Lausanne | College/University | Graduate Degree | |
Swiss Academy of Technical Sciences | Corporate Officer/Principal | ||
Young Global Leaders | Corporate Officer/Principal | ||
Radionetics Oncology, Inc.
Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Radionetics Oncology, Inc. is a clinical stage radiopharmaceutical company based in Menlo Park, CA. Radionetics Oncology, Inc. focuses on the discovery and development of novel radiotherapeutics for the treatment of various oncology indications. Radionetics Oncology spun out of Crinetics Pharmaceuticals and is supported by Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, and GordonMD Investments. The company is advancing a pipeline of small molecule radioligands that target G-protein coupled receptors to treat a wide range of cancers, including adrenocortical carcinoma, breast cancer, and lung cancer. The company's platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes selectively to tumors expressing peptide receptors. The company's pipeline consists of multiple lead drug candidates, and they are conducting additional drug discovery efforts in collaboration with Crinetics Pharmaceuticals. The market for radiopharmaceuticals is expected to rise to $12.6 billion by 2027. The company was founded by Scott R. Struthers, and Paul A. Grayson has been the CEO since 2024. | Pharmaceuticals: Major | Chief Executive Officer | |
Crocus Technology International Corp.
Crocus Technology International Corp. SemiconductorsElectronic Technology Crocus Technology SA develops magnetically enhanced semiconductor technologies. Its products include microcontrollers, magnetic logic units, access control, CTMP memory, and magnetic sensors. The firm’s services encompass licensing and design. It caters to mobile phone manufacturers. The company was founded by Jean-Pierre Nozieres, Jean-Pierre Braun, Thierry Chavigner and Jacques Noels in 2004 and is headquartered in Grenoble, France. | Semiconductors | Director/Board Member | |
Natron Energy, Inc.
Natron Energy, Inc. Miscellaneous Commercial ServicesCommercial Services Natron Energy, Inc. develops batteries. It is developing a radical new battery technology for stationary applications including renewables support, smart grids/microgrids, and UPS. The company was founded by Robert Huggins and Colin Wessells in 2012 and is headquartered in Santa Clara, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Placon Therapeutics, Inc.
Placon Therapeutics, Inc. BiotechnologyHealth Technology Placon Therapeutics, Inc. develops novel platinum therapies. The private company is based in Watertown. | Biotechnology | Director/Board Member | |
VIEW OPERATING CORPORATION | Industrial Specialties | Director/Board Member | |
AEROCRINE AB | Electronic Equipment/Instruments | Chief Executive Officer | |
OREXO AB | Pharmaceuticals: Major | Director/Board Member | |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree | |
NanoDimension AG | Chief Executive Officer | ||
POSEIDA THERAPEUTICS, INC. | Biotechnology | President | |
AFYX Therapeutics AS
AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | Miscellaneous Commercial Services | Chief Executive Officer | |
Alita Pharmaceuticals, Inc.
Alita Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alita Pharmaceuticals, Inc. develops, manufactures and distributes urologic and female healthcare products. It offers product testing, research and development services. The company was founded by Carole S. Ben-Maimon and Warburg Pincus in September 2006 and is headquartered in Radnor, PA. | Pharmaceuticals: Major | Director/Board Member | |
Endo Ventures Ltd. | President | ||
INSMED INCORPORATED | Pharmaceuticals: Major | Investor Relations Contact | |
PROTARA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Warburg Pincus LLC
Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
Sprout Group
Sprout Group Investment ManagersFinance Sprout Group (Sprout) is venture capital subsidiary of Credit Suisse Private Equity LLC founded in 1969. The firm headquartered in New York. | Investment Managers | Corporate Officer/Principal | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member | |
CONNECT
CONNECT Miscellaneous Commercial ServicesCommercial Services CONNECT creates and scales companies in the technology and life sciences sectors. It creates an environment in which entrepreneurs and C-suite executives have access to the people, capital, and technology resources. The organization was founded in 1985 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member | |
LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO | |
Perelman School of Medicine | College/University | Doctorate Degree | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
Harvard College | College/University | Undergraduate Degree | |
Transposagen Biopharmaceuticals, Inc.
Transposagen Biopharmaceuticals, Inc. BiotechnologyHealth Technology Transposagen Biopharmaceuticals, Inc. operates as a biotechnology company. Its products and services include piggyBac Reagents, cell engineering services and gene editing reagents & kits. The company was founded by Ostertag M. Eric in 2005 and is headquartered in Lexington, KY. | Biotechnology | Director/Board Member | |
UCB | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | ||
Anodyne Nanotech, Inc.
Anodyne Nanotech, Inc. BiotechnologyHealth Technology Anodyne Nanotech, Inc. operates as a preclinical-stage biotech company. It develops differentiated and transdermal forms of high-value drugs. The company is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
Gemstone Biotherapeutics LLC
Gemstone Biotherapeutics LLC BiotechnologyHealth Technology Gemstone Biotherapeutics LLC develops therapeutics and devices for wound care. It develops a range of tissue engineering inventions with particular emphasis on vascularization and angiogenesis for health care research and clinical markets. The company was founded in October 2013 and is headquartered in Baltimore, MD. | Biotechnology | Chief Executive Officer | |
The Johns Hopkins University | College/University | Chief Executive Officer | |
University of Hamburg | College/University | Doctorate Degree | |
University of Freiburg | College/University | Graduate Degree | |
Bayer Yakuhin Ltd.
Bayer Yakuhin Ltd. Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Bayer Yakuhin Ltd. is a Japanese company that manufactures pharmaceuticals and diagnostic substances. The company is based in Osaka, Japan. | Pharmaceuticals: Major | President |
Statistics
International
United States | 37 |
Switzerland | 4 |
Sweden | 3 |
Germany | 3 |
Cayman Islands | 2 |
Sectoral
Health Technology | 22 |
Consumer Services | 11 |
Commercial Services | 8 |
Finance | 4 |
Process Industries | 3 |
Operational
Director/Board Member | 85 |
Corporate Officer/Principal | 31 |
Independent Dir/Board Member | 25 |
Chairman | 22 |
Chief Executive Officer | 19 |
Most connected contacts
Insiders | |
---|---|
Patrick Zenner | 24 |
Carrie Cox | 22 |
Timothy Barabe | 21 |
Timothy Springer | 19 |
Nishan de Silva | 18 |
Scott Myers | 18 |
Aymeric Sallin | 14 |
Michael Singer | 12 |
Blaine Davis | 10 |
Carsten Brunn | 10 |
Kristen Baldwin | 6 |
Matthew Bartholomae | 5 |
Emily English | 5 |
Chris Jewell | 4 |
Metin Kurtoglu | 2 |
- Stock Market
- Insiders
- Murat Kalayoglu
- Company connections